TROZX | VIHAX | TROZX / VIHAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 5 years | 9 years | - |
Gain YTD | 8.729 | 6.366 | 137% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.6B | 8.54B | 148% |
Annual Yield % from dividends | 3.37 | 4.87 | 69% |
Returns for 1 year | 16.95 | 8.51 | 199% |
Returns for 3 years | 31.12 | 8.69 | 358% |
Returns for 5 years | N/A | 23.63 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
UEVM | 47.67 | -0.35 | -0.72% |
VictoryShares Emerging Mkts Val MomtETF | |||
RAYE | 23.43 | -0.17 | -0.72% |
Rayliant Quantamental Emer Mkt Eq ETF | |||
IHI | 64.36 | -0.48 | -0.74% |
iShares US Medical Devices ETF | |||
FLN | 16.99 | -0.19 | -1.11% |
First Trust Latin America AlphaDEX® ETF | |||
KOLD | 20.84 | -0.50 | -2.34% |
ProShares UltraShort Bloomberg Natrl Gas |